Motion sickness

Defender Pharmaceuticals Receives Complete Response Letter from the U.S. Food and Drug Administration for its Intranasal Scopolamine (DPI-386) New Drug Application for the Prevention of Nausea and Vomiting Induced by Motion in Adults

Retrieved on: 
Tuesday, January 30, 2024

ST. LOUIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences company based in St. Louis, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company’s New Drug Application (NDA) for intranasal scopolamine (DPI-386) for the prevention of nausea and vomiting induced by motion in adults.

Key Points: 
  • ST. LOUIS, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Defender Pharmaceuticals, Inc. (the “Company” or “Defender”), a privately held life sciences company based in St. Louis, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to the Company’s New Drug Application (NDA) for intranasal scopolamine (DPI-386) for the prevention of nausea and vomiting induced by motion in adults.
  • “Following our review of the CRL, we plan on scheduling a formal meeting with the FDA to fully understand the issues raised in the CRL so we can develop and implement a comprehensive action plan,” said Barry I. Feinberg, M.D., President & CEO of Defender Pharmaceuticals.
  • “We remain confident that our intranasal scopolamine is a safe and effective therapy for the prevention of motion sickness, and we will work closely with the FDA to ensure that we can bring this innovative new product to the market.”

VMocion announces $3M seed round to advance its virtual motion technologies

Retrieved on: 
Wednesday, January 3, 2024

SCOTTSDALE, Ariz., Jan. 3, 2024 /PRNewswire/ -- VMocion, an entertainment technology company in Scottsdale, Arizona, announced today a $3M seed round for advancement of its VMocion 3V™ and WAIV™ technologies.

Key Points: 
  • SCOTTSDALE, Ariz., Jan. 3, 2024 /PRNewswire/ -- VMocion, an entertainment technology company in Scottsdale, Arizona, announced today a $3M seed round for advancement of its VMocion 3V™ and WAIV™ technologies.
  • VMocion's 3V™ technologies allow users to feel the motion they see.
  • A virtually stimulated sense of physical motion matches the motion seen on screen, creating an all-sensory experience.
  • Motion sickness occurs when humans feel motion without seeing that matching motion.

Hyundai Mobis to Assist Marine Corps in Reducing Motion Sickness in Armored Vehicles

Retrieved on: 
Thursday, December 28, 2023

Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.

Key Points: 
  • Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.
  • Importantly, this marks the first application of Hyundai Mobis's motion sickness reduction technology in the broader mobility sector beyond conventional vehicles.
  • Hyundai Mobis confirmed that this technology can prevent motion sickness by up to 70% and reduce the symptoms by 40%.
  • Hyundai Mobis will provide the Marine Corps with an integrated motion sickness reduction solution tailored for harsh environments, combining hardware and software.

Hyundai Mobis to Assist Marine Corps in Reducing Motion Sickness in Armored Vehicles

Retrieved on: 
Thursday, December 28, 2023

Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.

Key Points: 
  • Last year, Hyundai Mobis developed the 'Smart Cabin Controller,' analyzing a driver's posture, heart rate, and brainwaves to prevent drowsiness, stress, and motion sickness.
  • Importantly, this marks the first application of Hyundai Mobis's motion sickness reduction technology in the broader mobility sector beyond conventional vehicles.
  • Hyundai Mobis confirmed that this technology can prevent motion sickness by up to 70% and reduce the symptoms by 40%.
  • Hyundai Mobis will provide the Marine Corps with an integrated motion sickness reduction solution tailored for harsh environments, combining hardware and software.

Vetster and Air Canada’s First-of-its-Kind Partnership Unleashes an Innovative Era of On-the-Go Pet Care

Retrieved on: 
Tuesday, December 12, 2023

Vetster, the world's fastest growing veterinary telehealth and pet care marketplace, today announced its partnership with Air Canada to provide around-the-clock access to Vetster’s virtual veterinary services for pets traveling in cargo.

Key Points: 
  • Vetster, the world's fastest growing veterinary telehealth and pet care marketplace, today announced its partnership with Air Canada to provide around-the-clock access to Vetster’s virtual veterinary services for pets traveling in cargo.
  • Vetster aims to set a new standard for quality care, safety and peace of mind for millions of traveling pet parents.
  • Trained Air Canada personnel can now use Vetster on behalf of pet parents to connect with licensed veterinarians, who can support pets traveling in cargo and in need of medical assistance.
  • Pet parents are looking for transparent, effective and timely care for their pets when flying,” said Mark Bordo, CEO and Co-Founder of Vetster.

WAT Medical Joins World's Largest Boat Show

Retrieved on: 
Wednesday, December 13, 2023

VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ -- Discover Boating Miami International Boat Show (DBMIBS) is the world's largest boat and yacht show.

Key Points: 
  • VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ -- Discover Boating Miami International Boat Show (DBMIBS) is the world's largest boat and yacht show.
  • WAT Medical is a Canadian company that develops wearable medical technologies.
  • WAT Medical has partnered with VIKAND since the 2019 Seatrade Cruise Global conference to further expand EmeTerm's market.
  • British Journal of Anesthesiology
    View original content to download multimedia: https://www.prnewswire.com/news-releases/wat-medical-joins-worlds-larges...
    SOURCE WAT Medical Enterprise Ltd.

MARELLI'S FULLY ACTIVE ELECTRO-MECHANIC SUSPENSION SYSTEM HONORED AT THE "DIGITAL ENGINEERING AWARDS 2023"

Retrieved on: 
Wednesday, December 13, 2023

DETROIT, Dec. 13, 2023 /PRNewswire/ -- The Fully Active Electro-Mechanic Suspension System developed by Marelli has received the 'Commendable' honor at The Digital Engineering Awards 2023 .

Key Points: 
  • DETROIT, Dec. 13, 2023 /PRNewswire/ -- The Fully Active Electro-Mechanic Suspension System developed by Marelli has received the 'Commendable' honor at The Digital Engineering Awards 2023 .
  • "We are honored to receive the 'Commendable' designation at the 2023 Digital Engineering Awards for our state-of-the-art suspension technology," said Antonio Ferrara, president of Marelli's Ride Dynamics division.
  • Marelli's new Fully Active Electro-Mechanic Suspension System is a breakthrough in automotive technology, enhancing vehicle safety, performance, and comfort, while ensuring high efficiency.
  • The electronically-controlled system autonomously decides the best behavior of each vehicle's suspension, neutralizing vibration and vehicle body movements.

New Philips OlfaPure 7300 Smart Car Aroma Diffuser Let Drivers Match Scents to their Mood

Retrieved on: 
Wednesday, November 22, 2023

The innovative Philips OlfaPure 7200 scent diffuser allows drivers to make every trip more comfortable at the touch of a button.

Key Points: 
  • The innovative Philips OlfaPure 7200 scent diffuser allows drivers to make every trip more comfortable at the touch of a button.
  • The Philips OlfaPure 7300 is controlled by a smartphone app that employs an advanced spatial algorithm to control the aroma diffusion for an optimal experience.
  • Philips OlfaPure 7300 users can choose from an array of 10 different fragrances including three 'functional' scents and seven 'mood' scents.
  • "We believe that the Philips OlfaPure 7300 sets a new standard in aroma diffusers thanks to its impressive built-in technology and excellent scent offerings."

IDTechEx Reports on A Tale of Two Realities: Mapping Spatial Computing's Next Decade

Retrieved on: 
Monday, November 20, 2023

Butterscotch's display system approaches retinal resolution, which is the pixel density at which most people's eyes cannot distinguish individual pixels.

Key Points: 
  • Butterscotch's display system approaches retinal resolution, which is the pixel density at which most people's eyes cannot distinguish individual pixels.
  • This reduces the perception that the user is looking at screens, eliminating the "screen door effect" of the visible pixel grid.
  • A production-ready system would need a higher field of view, but this requires incredibly high-resolution screens and massive computing demands.
  • All reports feature multiple interview-based company profiles from key industry players in addition to SWOT analysis, readiness level assessments, and much more.

IDTechEx Reports on A Tale of Two Realities: Mapping Spatial Computing's Next Decade

Retrieved on: 
Monday, November 20, 2023

Butterscotch's display system approaches retinal resolution, which is the pixel density at which most people's eyes cannot distinguish individual pixels.

Key Points: 
  • Butterscotch's display system approaches retinal resolution, which is the pixel density at which most people's eyes cannot distinguish individual pixels.
  • This reduces the perception that the user is looking at screens, eliminating the "screen door effect" of the visible pixel grid.
  • A production-ready system would need a higher field of view, but this requires incredibly high-resolution screens and massive computing demands.
  • All reports feature multiple interview-based company profiles from key industry players in addition to SWOT analysis, readiness level assessments, and much more.